TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma
TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma
Active, not recruiting · NCT04988945 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-09-25 | NCT04988945 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Hong Kong | 349 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Surgery, The University of Hong Kong | Hong Kong | Hong Kong | 1 |
| The University of Hong Kong | Hong Kong | Hong Kong | 52 |